Eli Lilly Long-Term Investments 2010-2024 | LLY

Eli Lilly long-term investments for the quarter ending September 30, 2024 were $3.200B, a 18.89% increase year-over-year.

  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.
  • Eli Lilly long-term investments for 2021 were $3.213B, a 8.29% increase from 2020.

Eli Lilly Long-Term Investments 2010-2024 | LLY

  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.
  • Eli Lilly long-term investments for 2021 were $3.213B, a 8.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B